• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effect of purified, soluble urokinase receptor on the plasminogen-prourokinase activation system.

作者信息

Behrendt N, Danø K

机构信息

Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark.

出版信息

FEBS Lett. 1996 Sep 9;393(1):31-6. doi: 10.1016/0014-5793(96)00849-6.

DOI:10.1016/0014-5793(96)00849-6
PMID:8804418
Abstract

The extracellular proteolytic pathway mediated by the urokinase plasminogen activator (uPA) is a cascade system, initiated by activation of the zymogen, pro-uPA. Pro-uPA as well as uPA binds to the cellular uPA receptor (uPAR) which has a central function in cell-dependent acceleration of the cascade system. This role of uPAR is generally assumed to be a positioning effect since uPAR-expressing cells exclusively stimulate the activation of cell surface-bound plasminogen (Ellis et al. (1993) Methods Enzymol. 223, 223-233). However, it was recently reported that a recombinant, soluble uPAR (suPAR) was capable of accelerating plasminogen activation in solution (Higazi et al. (1995) J. Biol. Chem. 270, 17375-17380). In this work we show that suPAR as such has no accelerative role. In contrast, the progress of the activation reactions in a soluble system with pro-uPA and plasminogen was found to be attenuated by suPAR. This delay of the activation system was shown to include a partial inhibition of the plasmin-mediated activation of pro-uPA as well as of the uPA-mediated activation of plasminogen.

摘要

相似文献

1
Effect of purified, soluble urokinase receptor on the plasminogen-prourokinase activation system.
FEBS Lett. 1996 Sep 9;393(1):31-6. doi: 10.1016/0014-5793(96)00849-6.
2
Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).相互的尿激酶原/纤溶酶原激活动力学——由与聚(D-赖氨酸)结合的尿激酶受体形成的模板所刺激
Eur J Biochem. 1997 Apr 15;245(2):316-23. doi: 10.1111/j.1432-1033.1997.00316.x.
3
Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase.纤溶酶原激活过程中尿激酶细胞受体的功能分析。受体结合对尿激酶原的酶原性质无影响。
J Biol Chem. 1996 Jun 21;271(25):14779-84. doi: 10.1074/jbc.271.25.14779.
4
Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.受体介导的纤溶酶原激活物功能调节:两种直接膜锚定形式的尿激酶对纤溶酶原的激活作用
J Pept Sci. 2000 Sep;6(9):432-9. doi: 10.1002/1099-1387(200009)6:9<432::AID-PSC279>3.0.CO;2-Q.
5
Reply to comment on 'Effect of purified, soluble urokinase receptor on the plasminogen-prourokinase activation system' (A. A-R. Higazi).对“A. A-R. Higazi的《纯化的可溶性尿激酶受体对纤溶酶原-单链尿激酶激活系统的影响》评论的回复”
FEBS Lett. 1997 Feb 3;402(2-3):293-4. doi: 10.1016/s0014-5793(96)01534-7.
6
Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes.玻连蛋白通过捕获可溶性尿激酶受体-尿激酶复合物,将蛋白水解活性集中于细胞表面和细胞外基质。
Blood. 1998 Apr 1;91(7):2305-12.
7
Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.参与尿激酶-1型抑制剂复合物和尿激酶原与内吞性α2-巨球蛋白受体/低密度脂蛋白受体相关蛋白结合的区域。尿激酶受体保护尿激酶原不与内吞性受体结合的证据。
J Biol Chem. 1994 Oct 14;269(41):25668-76.
8
Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen.尿激酶受体介导的纤溶酶原激活复合物的组装涉及尿激酶和纤溶酶原之间直接的、非活性位点的相互作用。
Biochemistry. 1999 Jan 12;38(2):651-9. doi: 10.1021/bi981714d.
9
Inactivation of receptor-bound pro-urokinase-type plasminogen activator (pro-uPA) by thrombin and thrombin/thrombomodulin complex.凝血酶及凝血酶/血栓调节蛋白复合物对受体结合型尿激酶型纤溶酶原激活剂(pro-uPA)的灭活作用
Biol Chem Hoppe Seyler. 1994 Sep;375(9):603-8. doi: 10.1515/bchm3.1994.375.9.603.
10
Characterization of cell-associated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87).尿激酶型纤溶酶原激活剂催化的细胞相关纤溶酶原激活的特征,但独立于尿激酶受体(uPAR,CD87)。
Blood. 1999 Jun 1;93(11):3839-46.

引用本文的文献

1
The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review.尿激酶型纤溶酶原激活物及其受体对胸膜和实质肺损伤与修复的作用:一个叙述性综述。
Int J Mol Sci. 2021 Feb 1;22(3):1437. doi: 10.3390/ijms22031437.
2
Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients.可溶性尿激酶型纤溶酶原激活物受体(suPAR)水平升高与阵发性夜间血红蛋白尿(PNH)患者的血栓形成及纤溶酶生成抑制有关。
Exp Hematol. 2008 Dec;36(12):1616-24. doi: 10.1016/j.exphem.2008.06.016. Epub 2008 Oct 26.
3
The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation.
在丝氨酸蛋白酶抑制剂型抑制剂和尿激酶受体存在的情况下,前尿激酶纤溶酶原激活系统:通过相互的酶原激活来挽救活性。
Biochem J. 2003 Apr 15;371(Pt 2):277-87. doi: 10.1042/BJ20021508.